KD-414
id:
kd-414-268-8090427
title:
KD-414
text:
KD-414 is a COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co. Results of a phase 1/2 clinical trial for this vaccine were released as a preprint in June 2022.
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine candidate against COVID-19
original url:
https://en.wikipedia.org/wiki/KD-414
date created:
date modified:
2023-12-30T09:19:24Z
main entity:
{"identifier":"Q110269777","url":"https://www.wikidata.org/entity/Q110269777"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15